# Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

> **NCT04644016** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 31 (estimated)

## Conditions studied

- AML
- ALL
- MDS
- MPD Withou Myelofibrosis
- NHL or HL
- Inherited Metabolic Disorders
- Hemoglobinopathies
- Bone Marrow Failure
- HLH

## Interventions

- **DRUG:** Clofarabine
- **DRUG:** Fludarabine
- **DRUG:** Busulfan
- **DRUG:** Cyclosporine-A
- **DRUG:** Mycophenolate Mofetil
- **BIOLOGICAL:** Cord Blood Graft

## Key facts

- **NCT ID:** NCT04644016
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-20
- **Primary completion:** 2026-12-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04644016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04644016, "Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04644016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*